Cargando…

Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics

BACKGROUND: The mechanisms of doxorubicin (DOX) cardiotoxicity were complex and controversial, with various contradictions between experimental and clinical data. Understanding the differences in the molecular mechanism between DOX-induced acute and chronic cardiotoxicity may be an ideal entry point...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Hongyan, Qian, Yi, Liu, Yi, Cao, Jiaxin, Wang, Yuhang, Yang, Aihua, Zhao, Wenjing, Lu, Yingnan, Liu, Huanxin, Zhu, Weizhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874088/
https://www.ncbi.nlm.nih.gov/pubmed/36712272
http://dx.doi.org/10.3389/fcvm.2022.996809
_version_ 1784877726657675264
author Qian, Hongyan
Qian, Yi
Liu, Yi
Cao, Jiaxin
Wang, Yuhang
Yang, Aihua
Zhao, Wenjing
Lu, Yingnan
Liu, Huanxin
Zhu, Weizhong
author_facet Qian, Hongyan
Qian, Yi
Liu, Yi
Cao, Jiaxin
Wang, Yuhang
Yang, Aihua
Zhao, Wenjing
Lu, Yingnan
Liu, Huanxin
Zhu, Weizhong
author_sort Qian, Hongyan
collection PubMed
description BACKGROUND: The mechanisms of doxorubicin (DOX) cardiotoxicity were complex and controversial, with various contradictions between experimental and clinical data. Understanding the differences in the molecular mechanism between DOX-induced acute and chronic cardiotoxicity may be an ideal entry point to solve this dilemma. METHODS: Mice were injected intraperitoneally with DOX [(20 mg/kg, once) or (5 mg/kg/week, three times)] to construct acute and chronic cardiotoxicity models, respectively. Survival record and ultrasound monitored the cardiac function. The corresponding left ventricular (LV) myocardium tissues were analyzed by RNA-seq to identify differentially expressed genes (DEGs). Gene Ontology (GO), Kyoto Encyclopedia of Gene and Genome (KEGG), and Gene Set Enrichment Analysis (GSEA) found the key biological processes and signaling pathways. DOX cardiotoxicity datasets from the Gene expression omnibus (GEO) database were combined with RNA-seq to identify the common genes. Cytoscape analyzed the hub genes, which were validated by quantitative real-time PCR. ImmuCo and ImmGen databases analyzed the correlations between hub genes and immunity-relative markers in immune cells. Cibersort analyzed the immune infiltration and correlations between the hub genes and the immune cells. Logistic regression, receiver operator characteristic curve, and artificial neural network analysis evaluated the diagnosis ability of hub genes for clinical data in the GEO dataset. RESULTS: The survival curves and ultrasound monitoring demonstrated that cardiotoxicity models were constructed successfully. In the acute model, 788 DEGs were enriched in the activated metabolism and the suppressed immunity-associated signaling pathways. Three hub genes (Alas1, Atp5g1, and Ptgds) were upregulated and were negatively correlated with a colony of immune-activating cells. However, in the chronic model, 281 DEGs showed that G protein-coupled receptor (GPCR)-related signaling pathways were the critical events. Three hub genes (Hsph1, Abcb1a, and Vegfa) were increased in the chronic model. Furthermore, Hsph1 combined with Vegfa was positively correlated with dilated cardiomyopathy (DCM)-induced heart failure (HF) and had high accuracy in the diagnosis of DCM-induced HF (AUC = 0.898, P = 0.000). CONCLUSION: Alas1, Atp5g1, and Ptgds were ideal biomarkers in DOX acute cardiotoxicity. However, Hsph1 and Vegfa were potential biomarkers in the myocardium in the chronic model. Our research, first, provided bioinformatics and clinical evidence for the discovery of the differences in mechanism and potential biomarkers of DOX-induced acute and chronic cardiotoxicity to find a therapeutic strategy precisely.
format Online
Article
Text
id pubmed-9874088
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98740882023-01-26 Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics Qian, Hongyan Qian, Yi Liu, Yi Cao, Jiaxin Wang, Yuhang Yang, Aihua Zhao, Wenjing Lu, Yingnan Liu, Huanxin Zhu, Weizhong Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: The mechanisms of doxorubicin (DOX) cardiotoxicity were complex and controversial, with various contradictions between experimental and clinical data. Understanding the differences in the molecular mechanism between DOX-induced acute and chronic cardiotoxicity may be an ideal entry point to solve this dilemma. METHODS: Mice were injected intraperitoneally with DOX [(20 mg/kg, once) or (5 mg/kg/week, three times)] to construct acute and chronic cardiotoxicity models, respectively. Survival record and ultrasound monitored the cardiac function. The corresponding left ventricular (LV) myocardium tissues were analyzed by RNA-seq to identify differentially expressed genes (DEGs). Gene Ontology (GO), Kyoto Encyclopedia of Gene and Genome (KEGG), and Gene Set Enrichment Analysis (GSEA) found the key biological processes and signaling pathways. DOX cardiotoxicity datasets from the Gene expression omnibus (GEO) database were combined with RNA-seq to identify the common genes. Cytoscape analyzed the hub genes, which were validated by quantitative real-time PCR. ImmuCo and ImmGen databases analyzed the correlations between hub genes and immunity-relative markers in immune cells. Cibersort analyzed the immune infiltration and correlations between the hub genes and the immune cells. Logistic regression, receiver operator characteristic curve, and artificial neural network analysis evaluated the diagnosis ability of hub genes for clinical data in the GEO dataset. RESULTS: The survival curves and ultrasound monitoring demonstrated that cardiotoxicity models were constructed successfully. In the acute model, 788 DEGs were enriched in the activated metabolism and the suppressed immunity-associated signaling pathways. Three hub genes (Alas1, Atp5g1, and Ptgds) were upregulated and were negatively correlated with a colony of immune-activating cells. However, in the chronic model, 281 DEGs showed that G protein-coupled receptor (GPCR)-related signaling pathways were the critical events. Three hub genes (Hsph1, Abcb1a, and Vegfa) were increased in the chronic model. Furthermore, Hsph1 combined with Vegfa was positively correlated with dilated cardiomyopathy (DCM)-induced heart failure (HF) and had high accuracy in the diagnosis of DCM-induced HF (AUC = 0.898, P = 0.000). CONCLUSION: Alas1, Atp5g1, and Ptgds were ideal biomarkers in DOX acute cardiotoxicity. However, Hsph1 and Vegfa were potential biomarkers in the myocardium in the chronic model. Our research, first, provided bioinformatics and clinical evidence for the discovery of the differences in mechanism and potential biomarkers of DOX-induced acute and chronic cardiotoxicity to find a therapeutic strategy precisely. Frontiers Media S.A. 2023-01-11 /pmc/articles/PMC9874088/ /pubmed/36712272 http://dx.doi.org/10.3389/fcvm.2022.996809 Text en Copyright © 2023 Qian, Qian, Liu, Cao, Wang, Yang, Zhao, Lu, Liu and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Qian, Hongyan
Qian, Yi
Liu, Yi
Cao, Jiaxin
Wang, Yuhang
Yang, Aihua
Zhao, Wenjing
Lu, Yingnan
Liu, Huanxin
Zhu, Weizhong
Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics
title Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics
title_full Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics
title_fullStr Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics
title_full_unstemmed Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics
title_short Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics
title_sort identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874088/
https://www.ncbi.nlm.nih.gov/pubmed/36712272
http://dx.doi.org/10.3389/fcvm.2022.996809
work_keys_str_mv AT qianhongyan identificationofnovelbiomarkersinvolvedindoxorubicininducedacuteandchroniccardiotoxicityrespectivelybyintegratedbioinformatics
AT qianyi identificationofnovelbiomarkersinvolvedindoxorubicininducedacuteandchroniccardiotoxicityrespectivelybyintegratedbioinformatics
AT liuyi identificationofnovelbiomarkersinvolvedindoxorubicininducedacuteandchroniccardiotoxicityrespectivelybyintegratedbioinformatics
AT caojiaxin identificationofnovelbiomarkersinvolvedindoxorubicininducedacuteandchroniccardiotoxicityrespectivelybyintegratedbioinformatics
AT wangyuhang identificationofnovelbiomarkersinvolvedindoxorubicininducedacuteandchroniccardiotoxicityrespectivelybyintegratedbioinformatics
AT yangaihua identificationofnovelbiomarkersinvolvedindoxorubicininducedacuteandchroniccardiotoxicityrespectivelybyintegratedbioinformatics
AT zhaowenjing identificationofnovelbiomarkersinvolvedindoxorubicininducedacuteandchroniccardiotoxicityrespectivelybyintegratedbioinformatics
AT luyingnan identificationofnovelbiomarkersinvolvedindoxorubicininducedacuteandchroniccardiotoxicityrespectivelybyintegratedbioinformatics
AT liuhuanxin identificationofnovelbiomarkersinvolvedindoxorubicininducedacuteandchroniccardiotoxicityrespectivelybyintegratedbioinformatics
AT zhuweizhong identificationofnovelbiomarkersinvolvedindoxorubicininducedacuteandchroniccardiotoxicityrespectivelybyintegratedbioinformatics